Journal of
eISSN: 2373-6437
Submit manuscript...
Research Article Volume 14 Issue 1
Comparison of the intensive care unit admission rate and mortalities of COVID-19 patients who received Hydroxychloroquine and Favipiravir in the ward
Ahmet Eroglu, Seyfi Kartal, Esra Kongur
Received: January 20, 2022 | Published: February 14, 2022
Abstract
Until now, a fully accepted treatment method for the management of COVID-19 has not been recommended. Some antiviral drugs such favipiravir and remdesivir, antimalarial drugs like hydroxychloroquine and anti-inflammatory drugs have been used for the treatment of the patients with COVID-19. The aim of this retrospective study is to compare the Intensive Care Unit (ICU) admission rate and mortalities of COVID-19 patients who received Hydroxychloroquine and Favipiravir in the COVID positive wards.
©2022 , et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
Citations
Media Partner & Supporters
